{"name":"Therion Biologics Corporation","slug":"therion-biologics-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PANVAC™-VF","genericName":"PANVAC™-VF","slug":"panvac-vf","indication":"Metastatic colorectal cancer","status":"phase_3"}]}],"pipeline":[{"name":"PANVAC™-VF","genericName":"PANVAC™-VF","slug":"panvac-vf","phase":"phase_3","mechanism":"PANVAC-VF is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing ras and CEA tumor-associated antigens.","indications":["Metastatic colorectal cancer","Pancreatic cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMS1lNWRtelBjRDlVYm5lNzZvbjN3Wm1wUTV0ZGhNQ09YQ1dMdnJkTmtvbDFWM25MM1RfWHJlM3RHdzE1SzBfNTB0VkF3LS1HQTEtZTBoaVNQR093SWxXX3h4c0d6RnFJd0dHSkdicnVGOG9sYnVXMm40TmQyLTJnRDNiVmxTdmZrakUyNER5bHhIcDVNdlljRUE5TmFDVWw3RDAzc2M5eUVDWjBFbzFrdXktZ2NXaFBEelAteks5dGZ2dw?oc=5","date":"2023-04-24","type":"pipeline","source":"businesswire.com","summary":"Strand Therapeutics Appoints Colleen Wilson as Chief People Officer - businesswire.com","headline":"Strand Therapeutics Appoints Colleen Wilson as Chief People Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBDSzBlS3FDR0U1WmhKRXNXSXRHTTlfYzh0UE4ydGtTdW14U3YzdUhTekcyV0F6bzgwd3gxVUZWWFh2Xy13Z0dPSUlyc2xfLTN5THNMN2xR?oc=5","date":"2018-01-06","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}